These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8814360)

  • 1. Comparison of N-terminal pro-atrial natriuretic peptide and atrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits.
    Boomsma F; Bhaggoe UM; Man in 't Veld AJ; Schalekamp MA
    Clin Chim Acta; 1996 Aug; 252(1):41-9. PubMed ID: 8814360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice.
    Buckley MG; Marcus NJ; Yacoub MH
    Clin Sci (Lond); 1999 Dec; 97(6):689-95. PubMed ID: 10585896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure.
    Buckley MG; Sagnella GA; Markandu ND; Singer DR; MacGregor GA
    Clin Sci (Lond); 1989 Nov; 77(5):573-9. PubMed ID: 2531055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved radioimmunoassay of atrial natriuretic peptide in plasma.
    Poiesi C; Rodella A; Mantero G; Cannella G; Ferrari R; Albertini A
    Clin Chem; 1989 Jul; 35(7):1431-4. PubMed ID: 2527094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
    Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
    Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro atrial natriuretic peptide in human plasma.
    Buckley MG; Sagnella GA; Markandu ND; Singer DR; MacGregor GA
    Am J Hypertens; 1990 Dec; 3(12 Pt 1):933-5. PubMed ID: 2150487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism.
    Kiely DG; Kennedy NS; Pirzada O; Batchelor SA; Struthers AD; Lipworth BJ
    Respir Med; 2005 Oct; 99(10):1286-91. PubMed ID: 16099151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
    Loke I; Squire IB; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
    Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.
    Bentzen H; Pedersen RS; Pedersen HB; Nyvad O; Pedersen EB
    Clin Sci (Lond); 2003 Mar; 104(3):303-12. PubMed ID: 12605591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-atrial natriuretic peptide (1-98): the circulating cardiodilatin in man.
    Meleagros L; Ghatei MA; Gibbs JS; Bloom SR
    Peptides; 1989; 10(3):545-50. PubMed ID: 2528725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive N-terminal fragment of proatrial natriuretic peptide, ANP (1-98), in plasma of healthy dogs and dogs with impaired volume regulation: a comparison with the C-terminal ANP (99-126).
    Vollmar AM
    Res Vet Sci; 1991 May; 50(3):264-8. PubMed ID: 1831927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction.
    Kettunen RV; Leppäluoto J; Jounela A; Vuolteenaho O
    Am Heart J; 1994 Jun; 127(6):1449-55. PubMed ID: 8197967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart disease.
    Heringlake M; Kox T; Poeling J; Klaus S; Hanke T; Franz N; Eberhardt F; Heinze H; Armbruster FP; Bahlmann L
    Eur J Med Res; 2009 Mar; 14(3):106-12. PubMed ID: 19380280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.